How Type II CRISPR-Cas establish immunity through Cas1-Cas2 mediated spacer integration

por Xiao, Yibei, Ng, Sherwin, Nam, Ki Hyun, Ke, Ailong
Publicado 2017

Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor

por Wu, Qianqian, Yan, Shiqiang, Wang, Yujie, Li, Maotian, Xiao, Yibei, Li, Yingxia
Publicado 2022

Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus

por Sulimov, Alexey, Kutov, Danil, Ilin, Ivan, Xiao, Yibei, Jiang, Sheng, Sulimov, Vladimir
Publicado 2022

A unique GCN5-related glucosamine N-acetyltransferase region exist in the fungal multi-domain glycoside hydrolase family 3 β-N-acetylglucosaminidase

por Qin, Zhen, Xiao, Yibei, Yang, Xinbin, Mesters, Jeroen R., Yang, Shaoqing, Jiang, Zhengqiang
Publicado 2015

Real-time Observation of CRISPR spacer acquisition by Cas1–Cas2 integrase

por Budhathoki, Jagat B., Xiao, Yibei, Schuler, Gabriel, Hu, Chunyi, Cheng, Alexander, Ding, Fran, Ke, Ailong
Publicado 2020

Sequence specific integration by the family 1 casposase from Candidatus Nitrosopumilus koreensis AR1

por Wang, Xiaoke, Yuan, Qinling, Zhang, Wenxuan, Ji, Suyu, Lv, Yang, Ren, Kejing, Lu, Meiling, Xiao, Yibei
Publicado 2021

Elucidation of the 1-phenethylisoquinoline pathway from an endemic conifer Cephalotaxus hainanensis

por Qiao, Fei, He, Yuedong, Zhang, Yuhao, Jiang, Xuefei, Cong, Hanqing, Wang, Zhiming, Sun, Huapeng, Xiao, Yibei, Zhao, Yucheng, Nick, Peter
Publicado 2022

Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 M(pro))

por Zhang, Kuojun, Wang, Tianyu, Li, Maotian, Liu, Mu, Tang, He, Wang, Lin, Ye, Ke, Yang, Jiamei, Jiang, Sheng, Xiao, Yibei, Xie, Youhua, Lu, Meiling, Zhang, Xiangyu
Publicado 2023

Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation

por Huo, Yanwu, Nam, Ki Hyun, Ding, Fang, Lee, Heejin, Wu, Lijie, Xiao, Yibei, Farchione, F. Daniel, Zhou, Sharleen, Rajashankar, Raj, Kurinov, Igor, Zhang, Rongguang, Ke, Ailong
Publicado 2014

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

por Gu, Chunyan, Wang, Yajun, Zhang, Lulin, Qiao, Li, Sun, Shanliang, Shao, Miaomiao, Tang, Xiaozhu, Ding, Pinggang, Tang, Chao, Cao, Yuhao, Zhou, Yanyan, Guo, Mengjie, Wei, Rongfang, Li, Nianguang, Xiao, Yibei, Duan, Jinao, Yang, Ye
Publicado 2023

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

por Gu, Chunyan, Wang, Yajun, Zhang, Lulin, Qiao, Li, Sun, Shanliang, Shao, Miaomiao, Tang, Xiaozhu, Ding, Pinggang, Tang, Chao, Cao, Yuhao, Zhou, Yanyan, Guo, Mengjie, Wei, Rongfang, Li, Nianguang, Xiao, Yibei, Duan, Jinao, Yang, Ye
Publicado 2022

Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer

por Yuan, Kai, Li, Zhaoxing, Kuang, Wenbin, Wang, Xiao, Ji, Minghui, Chen, Weijiao, Ding, Jiayu, Li, Jiaxing, Min, Wenjian, Sun, Chengliang, Ye, Xiuquan, Lu, Meiling, Wang, Liping, Ge, Haixia, Jiang, Yuzhang, Hao, Haiping, Xiao, Yibei, Yang, Peng
Publicado 2022

Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents

por Sun, Chengliang, Cheng, Yao, Liu, Xiaojia, Wang, Gefei, Min, Wenjian, Wang, Xiao, Yuan, Kai, Hou, Yi, Li, Jiaxing, Zhang, Haolin, Dong, Haojie, Wang, Liping, Lou, Chenguang, Sun, Yanze, Yu, Xinmiao, Deng, Hongbin, Xiao, Yibei, Yang, Peng
Publicado 2022